ZOLL® Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, has announced that the company’s ZOLL AED 3 ™ and the ZOLL AED 3™ BLS (basic life support) automated external defibrillators now feature RapidShock™ Analysis technology, which decreases heart analysis time and pauses in chest compressions.
RapidShock Analysis can analyse a heart rhythm in three seconds, compared to existing devices, which take up to 12 seconds. Minimising CPR pause time for more continuous lifesaving CPR care can improve patient outcomes from sudden cardiac arrest. RapidShock Analysis is a free upgrade to existing ZOLL AED 3 owners in countries where it has regulatory approval.
Research shows that minimising time to shock after the CPR cycle ends may improve survival.1 The 2015 ERC Guidelines note, ‘The delay between stopping chest compressions and delivery of the shock (the pre-shock pause) must be kept to an absolute minimum; any delay will reduce the chances of the shock being successful’.2
The ZOLL AED 3 is designed and built upon years of usability research with both trained and untrained rescuers. The ZOLL AED 3 offers rescuers unmatched support with enhanced Real CPR Help®, ZOLL’s real-time CPR feedback technology. The ZOLL AED 3 is equipped with universal adult/paediatric electrode pads and a battery that lasts five years, which means less maintenance, a lower cost of ownership, and an AED that will be ready for the rescue.
The AED 3 has enhanced features such as integrated paediatric rescue capabilities and WiFi connectivity, which allows users to easily manage their suite of devices via the cloud. For professional rescuers, the ZOLL AED 3 BLS model provides an ECG display and CPR Dashboard™, for more in-depth rescue support .
References:
1. Snyder DE, et al. Crit Care Med. 2004; 32(9) Supplement:S421-S424.
2. ERC Guidelines for Resuscitation 2015. Resuscitation. 2015; 95:20.
